Clinical Trial

Assessment of Drug Liking In Peri-procedural Clinical Settings

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-03; most recent amendment 2026-05-06.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-11
Trial Details
NCT Number NCT07015528
Lead Sponsor Stanford University
Conditions Drug Liking
Enrollment 130 participants
Start Date 2025-09-30
Primary Completion 2026-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-08